BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25765390)

  • 1. Re: First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG).
    Richie JP
    J Urol; 2015 Mar; 193(3):850. PubMed ID: 25765390
    [No Abstract]   [Full Text] [Related]  

  • 2. First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG).
    Berger LA; Bokemeyer C; Lorch A; Hentrich M; Kopp HG; Gauler TC; Beyer J; de Wit M; Mayer F; Boehlke I; Oing C; Honecker F; Oechsle K
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1211-20. PubMed ID: 24696231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel, ifosfamide and cisplatin (TIP) beyond its original indication for salvage treatment of germ cell tumors.
    Voss MH; Feldman DR
    Onkologie; 2011; 34(8-9):410-1. PubMed ID: 21934338
    [No Abstract]   [Full Text] [Related]  

  • 4. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.
    Park S; Lee S; Lee J; Park SH; Park JO; Kang WK; Park YS; Lim HY
    Onkologie; 2011; 34(8-9):416-20. PubMed ID: 21934340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germ-cell tumors.
    Kondagunta V; Galsky MD; Sonpavde G
    N Engl J Med; 2007 Oct; 357(17):1773; author reply 1773-4. PubMed ID: 17969229
    [No Abstract]   [Full Text] [Related]  

  • 6. The Role of Salvage High-Dose Chemotherapy in Relapsed Male Germ Cell Tumors.
    Oing C; Lorch A
    Oncol Res Treat; 2018; 41(6):365-369. PubMed ID: 29843143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of salvage surgery following chemotherapy in advanced testicular cancer].
    Miki T; Saki S; Kotake T
    Hinyokika Kiyo; 1994 Oct; 40(10):951-5. PubMed ID: 7992713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced testicular cancer: treatment choices in the "land of plenty".
    Garnick MB
    J Clin Oncol; 1985 Mar; 3(3):294-7. PubMed ID: 2579211
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cisplatin in the treatment of testicular carcinoma].
    van Groeningen CJ; Pinedo HM
    Ned Tijdschr Geneeskd; 1986 Nov; 130(44):1980-4. PubMed ID: 3022163
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment strategies in metastatic testicular cancer.
    Bokemeyer C; Schmoll HJ
    Eur Urol; 1993; 23 Suppl 2():50-2. PubMed ID: 8390363
    [No Abstract]   [Full Text] [Related]  

  • 11. Germ-cell tumors.
    Lorch A; Beyer J; Bokemeyer C
    N Engl J Med; 2007 Oct; 357(17):1772-3; author reply 1773-4. PubMed ID: 17969228
    [No Abstract]   [Full Text] [Related]  

  • 12. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
    Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
    Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PVB therapy for advanced testicular cancer].
    Nakao M; Nakagawa S; Toyoda K; Nukui M; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maegawa M; Miyakoda K
    Hinyokika Kiyo; 1989 Nov; 35(11):1871-5. PubMed ID: 2482672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors.
    Nonomura N; Oka D; Nishimura K; Nakayama M; Inoue H; Mizutani Y; Miki T; Okuyama A
    Int J Urol; 2007 Jun; 14(6):527-31. PubMed ID: 17593098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germ-cell tumors.
    De Giorgi U; Pedrazzoli P; Rosti G; ;
    N Engl J Med; 2007 Oct; 357(17):1773; author reply 1773-4. PubMed ID: 17969230
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
    Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germ-cell tumors.
    Shamash J; Stebbing J; Powles T
    N Engl J Med; 2007 Oct; 357(17):1771-2; author reply 1773-4. PubMed ID: 17960020
    [No Abstract]   [Full Text] [Related]  

  • 18. Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer.
    González-Billalabeitia E; Sepúlveda JM; Maroto P; Aparicio J; Arranz JA; Esteban E; Gironés R; López-Brea M; Mendez-Vidal MJ; Pinto A; Sastre J; de Prado DS; Terrasa J; Vázquez S; Powles T; Beyer J; Castellano D; Del Muro XG;
    Eur Urol Focus; 2017 Apr; 3(2-3):280-286. PubMed ID: 28753776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of ifosfamide in the treatment of nonseminomatous testicular cancer.
    Scheulen ME; Niederle N; Kath R; Wandl UB; Seeber S; Schmidt CG
    Prog Clin Biol Res; 1988; 269():439-50. PubMed ID: 2455912
    [No Abstract]   [Full Text] [Related]  

  • 20. Current treatment of high risk testis cancer.
    Schmoll HJ; Jordan K
    Eur J Cancer; 2009 Sep; 45 Suppl 1():433-5. PubMed ID: 19775661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.